RxSight cuts 2025 revenue guidance as lens device sales decline
Go back to RxSight cuts 2025 revenue guidance as lens device sales decline| (NASDAQ: RXST) | Delayed: 4.87 +0.27 (5.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.60 | 52 Week High | $ | |||
| Open | $4.63 | 52 Week Low | $ | |||
| Day High | $4.87 | P/E | N/A | |||
| Day Low | $4.48 | EPS | $ | |||
| Volume | 319,095 | |||||

